Endothelin-1 stimulates interleukin-6 secretion from 3T3-L1 adipocytes

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 3, 2009, Pages 213-218

  Chai, Shin Pei ^a   Chang, Yin Nan ^a   Fong, Jim C ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adipocyte; Endothelin 1; IL 6 promoter; Interleukin 6

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; TRANSCRIPTION FACTOR SP1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STIMULATION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA TRANSCRIPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVITY; GENETIC TRANSFECTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BASE SEQUENCE; DACTINOMYCIN; DNA PRIMERS; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-6; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 60249087257     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.12.002     Document Type: Article

References (44)

1. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
2. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., and Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33 (1990) 306-310
3. Saito Y., Nakao K., Mukoyama M., and Imura H. Increased plasma endothelin level in patients with essential hypertension. N. Engl. J. Med. 322 (1990) 205
4. Miyauchi T., Yanagisawa M., Iida K., et al. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am. Heart J. 123 (1992) 1092-1093
5. Koyama H., Tabata T., Nishzawa Y., Inoue T., Morii H., and Yamaji T. Plasma endothelin levels in patients with uraemia. Lancet 1 (1989) 991-992
6. Pernow J., Hemsen A., and Lundberg J.M. Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol. Scand. 137 (1989) 317-318
7. Maeda S., Jesmin S., Iemitsu M., et al. Weight loss reduces plasma endothelin-1 concentration in obese men. Exp. Biol. Med. (Maywood.) 231 (2006) 1044-1047
8. Pollare T., Lithell H., and Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39 (1990) 167-174
9. DeFronzo R.A. Glucose intolerance and aging. Diabetes Care 4 (1981) 493-501
10. Friedman J.E., Dohm G.L., Elton C.W., et al. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am. J. Physiol. 261 (1991) E87-E94
11. Igarashi M., Yamatani K., Fukase N., et al. Sepsis inhibits insulin-stimulated glucose transport in isolated rat adipocytes. Diabetes Res. Clin. Pract. 15 (1992) 213-218
12. Saltiel A.R. You are what you secrete. Nat. Med. 7 (2001) 887-888
13. Ottosson-Seeberger A., Lundberg J.M., Alvestrand A., and Ahlborg G. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol. Scand. 161 (1997) 211-220
14. Juan C.C., Fang V.S., Huang Y.J., Kwok C.F., Hsu Y.P., and Ho L.T. Endothelin-1 induces insulin resistance in conscious rats. Biochem. Biophys. Res. Commun. 227 (1996) 694-699
15. Jiang Z.Y., Zhou Q.L., Chatterjee A., et al. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 48 (1999) 1120-1130
16. Chou Y.C., Perng J.C., Juan C.C., et al. Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 202 (1994) 688-693
17. Ishibashi K.I., Imamura T., Sharma P.M., Huang J., Ugi S., and Olefsky J.M. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J. Clin. Invest. 107 (2001) 1193-1202
18. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
19. Smith U. Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance-is insulin resistance initiated in the adipose tissue?. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 897-904
20. Trayhurn P., and Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60 (2001) 329-339
21. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
22. Fernandez-Real J.M., and Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev. 24 (2003) 278-301
23. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7265-7270
24. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab 82 (1997) 4196-4200
25. Dekker M.J., Lee S., Hudson R., et al. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism 56 (2007) 332-338
26. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74 (2006) 443-477
27. Zhang S., Liu J., MacGibbon G., Dragunow M., and Cooper G.J. Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells. J. Mol. Biol. 324 (2002) 271-285
28. Chen W., Yu Y.L., Lee S.F., et al. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Mol. Cell Biol. 21 (2001) 4636-4646
29. Fong J.C., Kao Y.S., Tsai H.Y., Chiou Y.Y., and Chiou G.Y. Synergistic effect of endothelin-1 and cyclic AMP on glucose transport in 3T3-L1 adipocytes. Cell. Signal. 16 (2004) 811-821
30. Schneider M.P., Boesen E.I., and Pollock D.M. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 731-759
31. Boivin B., Chevalier D., Villeneuve L.R., Rousseau E., and Allen B.G. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J. Biol. Chem. 278 (2003) 29153-29163
32. Ishikawa K., Ihara M., Noguchi K., et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4892-4896
33. Usui I., Imamura T., Babendure J.L., et al. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol. Endocrinol. 19 (2005) 2760-2768
34. Albert P.R., and Robillard L. G protein specificity: traffic direction required. Cell. Signal. 14 (2002) 407-418
35. Rohrbach S., Engelhardt S., Lohse M.J., Werdan K., Holtz J., and Muller-Werdan U. Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6. Mol. Med. 13 (2007) 605-614
36. Nilsson M.B., rmaiz-Pena G., Takahashi R., et al. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J. Biol. Chem. 282 (2007) 29919-29926
37. Kao Y.S., and Fong J.C. Endothelin-1 induces glut1 transcription through enhanced interaction between Sp1 and NF-kappaB transcription factors. Cell. Signal. 20 (2008) 771-778
38. Kao Y.S., and Fong J.C. Endothelin-1 induction of Glut1 transcription in 3T3-L1 adipocytes involves distinct PKCepsilon- and p42/p44 MAPK-dependent pathways. Biochim. Biophys. Acta 1780 (2008) 154-159
39. Juan C.-C., Chang C.-L., Lai Y.-H., and Ho L.-T. Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1146-E1152
40. Hoene M., and Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes. Rev. 9 (2008) 20-29
41. Fong J.C., Kao Y.S., Tsai H., and Ho L.T. Endothelin-1 increases glucose transporter glut1 mRNA accumulation in 3T3-L1 adipocytes by a mitogen-activated protein kinase-dependent pathway. Cell. Signal. 13 (2001) 491-497
42. Rotter V., Nagaev I., and Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278 (2003) 45777-45784
43. Strawbridge A.B., and Elmendorf J.S. Phosphatidylinositol 4,5-bisphosphate reverses endothelin-1-induced insulin resistance via an actin-dependent mechanism. Diabetes 54 (2005) 1698-1705
44. LaPensee C.R., Hugo E.R., and Ben-Jonathan N. Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways. Endocrinology 149 (2008) 5415-5422